← Back to all trials
Recruiting
NCT00373841
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 500
Sponsor: University of Pittsburgh
Location: Michelle F MacPherson Pittsburgh Pennsylvania
Summary
The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.
Eligibility Criteria
Inclusion Criteria:
* Patients who are 18 or older
* Diagnosis of Idiopathic Pulmonary Fibrosis
* Treated at the Simmons Center
Exclusion Criteria:
* Other Lung Illness
Source: ClinicalTrials.gov (NCT00373841). StuddyBuddy aggregates publicly available trial information.
